Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1963 2
1964 3
1967 3
1968 3
1969 6
1970 3
1971 2
1972 2
1973 3
1974 12
1975 7
1976 7
1977 6
1978 9
1979 18
1980 10
1981 15
1982 13
1983 13
1984 13
1985 18
1986 18
1987 27
1988 27
1989 21
1990 25
1991 28
1992 12
1993 20
1994 34
1995 27
1996 33
1997 26
1998 37
1999 41
2000 26
2001 27
2002 37
2003 31
2004 32
2005 32
2006 36
2007 23
2008 31
2009 31
2010 27
2011 23
2012 29
2013 37
2014 48
2015 52
2016 51
2017 53
2018 61
2019 40
2020 50
2021 36
2022 63
2023 38
2024 49
2025 39

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,425 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Sun JM, Shen L, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, Cho BC, Mansoor W, Li SH, Sunpaweravong P, Maqueda MA, Goekkurt E, Hara H, Antunes L, Fountzilas C, Tsuji A, Oliden VC, Liu Q, Shah S, Bhagia P, Kato K; KEYNOTE-590 Investigators. Sun JM, et al. Among authors: tsuji a. Lancet. 2021 Aug 28;398(10302):759-771. doi: 10.1016/S0140-6736(21)01234-4. Lancet. 2021. PMID: 34454674 Clinical Trial.
Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial.
Shiozawa M, Sunakawa Y, Watanabe T, Ota H, Yasui H, Yabuno T, Tei M, Kochi M, Manaka D, Ohori H, Yamaguchi T, Sagawa T, Kotaka M, Kubota Y, Sekikawa T, Nakamura M, Takeuchi M, Ichikawa W, Fujii M, Tsuji A. Shiozawa M, et al. Among authors: tsuji a. Nat Commun. 2024 Nov 25;15(1):10217. doi: 10.1038/s41467-024-54460-2. Nat Commun. 2024. PMID: 39587053 Free PMC article. Clinical Trial.
Hepsin.
Kurachi K, Torres-Rosado A, Tsuji A. Kurachi K, et al. Among authors: tsuji a. Methods Enzymol. 1994;244:100-14. doi: 10.1016/0076-6879(94)44009-3. Methods Enzymol. 1994. PMID: 7845200 No abstract available.
Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer.
Yamada Y, Higuchi K, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Miwa H, Hamada C, Hyodo I. Yamada Y, et al. Among authors: tsuji a. Ann Oncol. 2015 Jan;26(1):141-148. doi: 10.1093/annonc/mdu472. Epub 2014 Oct 14. Ann Oncol. 2015. PMID: 25316259 Free article. Clinical Trial.
Adult-type scimitar syndrome.
Morikawa T, Kotoku A, Tsuji A, Ogo T, Nishii T. Morikawa T, et al. Among authors: tsuji a. Eur Heart J Cardiovasc Imaging. 2025 Jun 30;26(7):1308. doi: 10.1093/ehjci/jeaf076. Eur Heart J Cardiovasc Imaging. 2025. PMID: 40037378 No abstract available.
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.
Kato K, Kojima T, Hara H, Tsuji A, Yasui H, Muro K, Satoh T, Ogata T, Ishihara R, Goto M, Baba H, Nishina T, Han S, Iwakami K, Yatsuzuka N, Doi T. Kato K, et al. Among authors: tsuji a. Esophagus. 2024 Jul;21(3):306-318. doi: 10.1007/s10388-024-01053-z. Epub 2024 Apr 12. Esophagus. 2024. PMID: 38607538 Free PMC article. Clinical Trial.
Moyamoya Disease Complicating Ebstein's Anomaly.
Goto I, Okamoto R, Sato Y, Tsuji A, Tanigawa T, Dohi K. Goto I, et al. Among authors: tsuji a. Intern Med. 2022 Dec 15;61(24):3683-3686. doi: 10.2169/internalmedicine.9516-22. Epub 2022 May 14. Intern Med. 2022. PMID: 35569986 Free PMC article.
Transporter-mediated Drug Interactions.
Tsuji A. Tsuji A. Drug Metab Pharmacokinet. 2002;17(4):253-74. doi: 10.2133/dmpk.17.253. Drug Metab Pharmacokinet. 2002. PMID: 15618677 Free article.
JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease.
Imai Y, Kusano K, Aiba T, Ako J, Asano Y, Harada-Shiba M, Kataoka M, Kosho T, Kubo T, Matsumura T, Minamino T, Minatoya K, Morita H, Nishigaki M, Nomura S, Ogino H, Ohno S, Takamura M, Tanaka T, Tsujita K, Uchida T, Yamagishi H, Ebana Y, Fujita K, Ida K, Inoue S, Ito K, Kuramoto Y, Maeda J, Matsunaga K, Neki R, Sugiura K, Tada H, Tsuji A, Yamada T, Yamaguchi T, Yamamoto E, Kimura A, Kuwahara K, Maemura K, Minamino T, Morisaki H, Tokunaga K; Japanese Circulation Society, Japanese College of Cardiology, Japanese Society of Pediatric Cardiology and Cardiac Surgery Joint Working Group. Imai Y, et al. Among authors: tsuji a. Circ J. 2024 Nov 25;88(12):2022-2099. doi: 10.1253/circj.CJ-23-0926. Epub 2024 Sep 27. Circ J. 2024. PMID: 39343605 Free article. No abstract available.
1,425 results